Slider Category: Why the Promaxo MRI

Better clinical outcomes

October 20, 2024

Better clinical outcomes The Promaxo MRI System boasts a 77%¹ cancer detection rate, an increase of 33%² more clinically significant cancers, and 23%² upstaged

A workflow that works for you

October 20, 2024

A workflow that works for you Run clinic and perform MRI-targeted prostate interventions at the same time. Learn More

Easy access to MRI

October 20, 2024

Easy access to MRI Compact and easy to install, the Promaxo MRI System requires no major facility upgrades and fits

¹ Price, John H., et al. “Accurate Prostate Biopsies Using Low-Field Portable Intervention MRI in an Ambulatory Surgical Center.” IPCU, 2024.
² Sze, C., et al (2023). “Feasibility and preliminary clinical tolerability of low-field MRI-guided prostate biopsy.” The Prostate, 83(7), 656-662. https://doi.org/10.1002/pros.24499.
³ Sze, C., et al, (2022) “Cost-efficient analysis of a portable low field magnetic resonance imaging system for prostate cancer diagnosis.” Front. Urol.2:966862. doi: 10.3389/fruro.2022.966862.
⁴ Chiragzada, S., et al. “Advantageous Detection of Significant Prostate Cancer Using a Low-Field, Office-Based MRI System.” Cureus. 2022 Dec 1;14(12):e32105. doi:10.7759/cureus.32105. PMID: 36601170; PMCID: PMC9805358.
⁵ Data on file.
⁶ Xiang, Jianjian, et al. “Transperineal versus transrectal prostate biopsy in the diagnosis of prostate cancer: A systematic review and meta-analysis.ˮ World Journal of Surgical Oncology, vol. 17, no. 1,13 Feb. 2019, https://doi.org/10.1186/s12957-019-1573-0.
*The Promaxo Robot is not yet available for commercial sale.